It’s Performance Review Time, Fertility Industry!

It’s Performance Review Time, Fertility Industry!

Performance review time, already, for the fertility industry? Yes, it’s mid-October so let’s check in on the American Society for Reproductive Medicine (ASRM) confab. This year it’s billed as a Scientific Congress and EXPO. Per usual, there are a few eyebrow raisers. I followed #ASRM2016 on Twitter over coffee this morning. (A decision made easier as it was raining buckets here in California). Before long I engaged, respectfully, in a few discussions. Below are some of the highlights and observations. You can find more on Healthcare in America, which published…

HealthCARE vs. Health Business: True Fertility Medicine ‘Helpers’ Don’t Hide Statistics and Agendas

HealthCARE vs. Health Business: True Fertility Medicine ‘Helpers’ Don’t Hide Statistics and Agendas

It’s rare that male readers weigh in on the topic of fertility health and society’s response to the marketing of ‘fertility’ treatments. Such an occurrence introduced an added jolt to my morning coffee. More refreshing still were the “ah-has” that accompanied the insight-laden comment (a blog post unto itself really). Let’s annotate his comment further. Brian begins: Your blog reminds me of the importance of not letting hope replace reality. Immediately the famous quote from Charles Revson, founder of Revlon, popped to mind: “In the factory, we make cosmetics, in…